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vanillin dehydrogenase from Candida dubliniensis†
Suprama Datta,ab Uday S. Annapureb and David J. Timson*acA coding sequence (CD36-03230) from the yeast Candida dubliniensis
had been previously annotated as a vanillin dehydrogenase (VDH). The
corresponding protein (CD36-03230p) was recombinantly expressed
in Escherichia coli and analysed. The protein ismost likely a tetramer in
solution as judged by crosslinking and gel ﬁltration experiments.
CD36-03230p is an active aldehyde dehydrogenase favouring cyclic
and aromatic substrates. Positive cooperativity and substrate inhibition
were observed with some substrates. The redox cofactor NADP+ and
substrates aﬀected the thermal stability of the protein. Interestingly,
the enzyme had no detectable activity with vanillin suggesting that the
annotation is incorrect. It has been previously hypothesized that
a methionine residue at a key position in the active site of yeast
aldehyde dehydrogenases sterically hinders cyclic substrates and
restricts speciﬁcity to aliphatic aldehydes. Molecular modeling of
CD36-03230p demonstrates that it has an isoleucine residue (Ile-156)
at this position, further strengthening this hypothesis.Introduction
Mostmammalian aldehyde dehydrogenases (ALDHs) have a broad
specicity for aliphatic aldehydes, as well as some aromatic and
polycyclic aldehydes,1–3 thus rendering an important protective
enzymatic function against these xenobiotics. Eubacterial ALDHs,
on the other hand, exhibit relatively narrow substrate specicity
depending on their natural habitat and exposure to endogenous
and exogenous aldehyde reactive elements. Hence, characteriza-
tion of ALDHs capable of catalyzing the oxidation of aromatic
aldehydes has been well documented in bacteria.4–13
Vanillin dehydrogenase (VDH), a sub-class of benzaldehyde
dehydrogenases,3 is a critical enzyme for the degradation of ligninersity Belfast, Medical Biology Centre, 97
d.timson@brighton.ac.uk
ment, Institute of Chemical Technology
ciences, University of Brighton, Huxley
K
tion (ESI) available. See DOI:
0derived phenylpropanoids (such as vanillin, vanillate, caﬀeate, p-
coumarate, cinnamate and benzaldehyde). These aromatic alde-
hydes, especially vanillin, are abundant as avour and aromas in
food and cosmetic industries. It is important to elucidate the
structural and functional characteristics of these enzymes given
their potential role in food chemistry and biotechnology. This
group of enzymes has been characterized in a number of eubac-
terial species, including Pseudomonas uorescens,6 Pseudomonas
putida KT2440,13 Corynebacterium glutamicum,7 Rhodococcus jostii
RHA1,4 Amycolatopsis sp. strain ATCC 39116,8 Sphingomonas
paucimobilis SYK,9 and Micrococcus sp.10 Mammalian epithelial
ALDH1A and salivary ALDH3A1 typically show activity towards
a wide range of aromatic aldehyde substrates (including vanillin,
benzaldehyde, cinnamaldehyde, 4-hydroxynonenal).14 Plant
ALDH2 family members have also been observed to show a broad
aromatic substrate specicity range, but with no report of activity
with vanillin.15 Two ALDHs from white rot fungus Phanerochaete
chrysosporium which are translationally up-regulated with exoge-
nous addition of vanillin are active as VDHs.16
There are reports of recombinant vanillin production in
metabolically engineered baker's yeast harbouring heterologous
genes,17 but no studies are available focusing on the character-
ization of endogenous vanillin dehydrogenase enzymes in yeast
species. To date, a single protein sequence CD36-03230p
(accession number: XP_002416995) from Candida dubliniensis
genome has been provisionally annotated as a putative vanillin
dehydrogenase (Cd36_03230p). The purpose of this study was to
characterise the substrate specicity and oligomeric structure of
recombinant Cd36_03230p, in order to validate (or otherwise) its
putative role. The results were interpreted, in part, based on
results from our previous study which described two ALDHs
from Saccharomyces cerevisiae var. boulardii.18Methods
Recombinant expression and purication of Cd36_03230p
The coding sequence for Cd36_03230 (based on accession
number: XM_002416950) was synthesised following optimizationThis journal is © The Royal Society of Chemistry 2016
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View Article Onlineof the sequence for expression in Escherichia coli (GenScript NJ,
USA). The coding sequence was PCR-amplied and amplicons
were inserted into the E. coli expression vector pET46 Ek/LIC
(Merck-Millipore, Nottingham, UK) according to the manufac-
turer's instructions (note that this vector introduces bases coding
for the amino acid sequenceMAHHHHHHVDDDDK at the 50 end
of the coding sequence). Correct insertion into the vector was
veried by PCR and by DNA sequencing (GATC, London, UK) of
the insert.
The expression vector was used to transform competent E. coli
Rosetta™ (DE3) cells (Merck-Millipore) and colonies resulting
from this transformation were used to inoculate cultures (5 ml of
Luria Bertani medium (LB) supplemented with 100 mg ml1
ampicillin and 34 mg ml1 chloramphenicol) which were grown
at 37 C overnight (17–18 h) with orbital shaking. Each culture
was then diluted into 1 l of LB (supplemented with 100 mg ml1
ampicillin and 34 mg ml1 chloramphenicol), grown (with orbital
shaking) until A600 reached 0.6 to 1.0 (typically 5–6 h) at 30 C,
followed by a slow induction by adding 1.3 mM IPTG overnight
(12–16 h) at 16 C. These induction conditions were based on our
previous experience of working with a wide variety of recombi-
nant proteins. Cells were harvested by centrifugation (4200g for
15 min), resuspended in cell resuspension buﬀer (50 mM
HEPES–OH, pH 7$5, 150mMNaCl, 10% (v/v) glycerol) and stored
frozen at 80 C until the purication step.
For purication, cell suspensions were thawed, disrupted by
sonication on ice (three pulses at 100 W for 30 s with 30 s gaps
for cooling) and claried by centrifugation (20 000g, 20 min, 4
C). The supernatant was applied to a cobalt agarose column
(1 ml, His-Select, Sigma, Poole, UK) which had been pre-
equilibrated in buﬀer A (cell resuspension buﬀer, except
500 mM NaCl) and allowed to pass through by gravity. The
column was washed with 40 ml of buﬀer A and the protein
eluted with three 2 ml aliquots of buﬀer C (buﬀer A plus
250 mM imidazole). Protein containing fractions were identi-
ed by SDS-PAGE and dialysed overnight at 4 C against cell
resuspension buﬀer supplemented with 1 mM DTT. The
concentration of Cd36_03230p was determined by the method
of Bradford19 using BSA as a standard. The puried fractions
were frozen at 80 C in 20 ml aliquots.Bioinformatics and modeling
Multiple sequence (structure-based) alignments were carried out
for Cd36_03230p with known structures of aromatic aldehyde
dehydrogenases (class 3) such as benzaldehyde dehydrogenase
from Pseudomonas putida (PDB ID 3LV1), Corynebacterium glu-
tamicum (PDB ID 3R64) and a salicylaldehyde dehydrogenase
from Pseudomonas putida G7 (PDB ID 4JZ6) using T-Coﬀee
algorithm in Expresso template mode available at http://
www.tcoﬀee.org.20–22 Human retinal dehydrogenase 1 (PDB ID
4WB9)23 and human liver mitochondrial dehydrogenase (PDB ID
1CW3)24 were also incorporated into the alignment as members
of class 1 and class 2 ALDHs respectively to have an insight into
their relatedness with Cd36_03230p if any. The sequence
homology was evaluated using ESPript 3.0 available at http://
espript.ibcp.fr.25 The phylogenetic tree was constructed usingThis journal is © The Royal Society of Chemistry 2016ClustalW Phylogeny (version 2.1), a web-based service available
at http://www.ebi.ac.uk/Tools/msa/clustalw2/26 by neighbour-
joining method.27
An initial molecular model of the protein was generated
using Phyre2 (ref. 28) and energy minimized using YASARA.29 A
model of dimeric Cd36_03230p was generated by aligning two
copies of the model to the ALDH domains of Geobacter sulfur-
reducens PutA (PDB 4NMB30) and saving the two monomers into
a single protein structure (pdb) le. This initial, dimeric model
was then subjected to a second round of energy minimization
using YASARA. A tetrameric model was generated in the same
way using the tetrameric structure of sheep liver class 1 alde-
hyde dehydrogenase (1BXS31) as the template. These models are
available as ESI† to this paper.
Cross-linking
Crosslinking with bis(sulfosuccinimidyl)suberate (BS3; 50–800
mM) was carried out with 18 mM protein (diluted as required in
100 mM sodium phosphate buﬀer pH 7.4) in a total volume of 10
ml. Reaction mixtures were incubated at 30 C for 30 min before
addition of the crosslinker and then incubated at the same
temperature for a further 35 min. Reactions were stopped by
addition of an equal volume of SDS-loading buﬀer (120 mMTris–
HCl, pH 6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 5% (w/v) bromo-
phenol blue, 1% (w/v) DTT) and analysed by 10% SDS-PAGE.
Analytical gel ltration
Cd36_03230p (200 ml of a 60 mM puried protein aliquot) was
chromatographed on a Sephacryl S-300 (Pharmacia) column
(total volume, Vt ¼ 65.2 ml; void volume, V0 ¼ 15.1 ml) at a ow
rate of 1 ml min1. The column was equilibrated and developed
in buﬀer G (50 mM Tris–HCl, 17 mM Tris base, 150 mM sodium
chloride, pH 7.4).32–34 Fractions (1 ml) were collected and ana-
lysed for protein content by measuring the absorbance at
280 nm. Standard proteins (thyroglobulin, 669 kDa; albumin,
67 kDa and chymotrypsinogen, 25 kDa) were used to calibrate
the column. Their elution volumes (Ve) were used to calculate
Kav according to the equation:
Kav ¼ (Ve  V0)/(Vt  Ve)
The Stoke's radius (Rs) was estimated from the inverse
correlation of this parameter with Kav and the sedimentation
coeﬃcient (S20,w) was estimated from the molecular models
using WinHydroPRO 1.00.35 The sub-unit stoichiometry (n) was
then estimated using the equation:
nM ¼ S20,wNA(6phRs)/(1  v2r)
whereM is the molecular mass of a monomer (52 100 Da), NA is
Avogadro's number (6.023  1023 mol1), h is the viscosity of
the solvent (0.01 g cm1 s1), v2 is the partial specic volume
(0.73 g cm3 g1)36 and r is the density of the solvent (1.0 g cm3).
Values obtained with both the dimeric and tetrameric models of
Cd36_03230p were compared in order to see which t better to
the experimental data.RSC Adv., 2016, 6, 99774–99780 | 99775
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View Article OnlineALDH activity measurements and enzyme kinetic analysis
The enzyme assay was performed as described previously.7,37–39
Aldehyde dehydrogenase enzyme activity was monitored at
30 C using a ThermoScientic Multiskan™ Microplate spec-
trophotometer. The reactions contained 100 mM potassium
phosphate buﬀer (pH 7.3), 0.5 mM NADP+, varied concentra-
tions of substrates (10–1200 mM) and 0.6 mM enzyme. The long-
chain (C8–C13) and phenolic aldehydes were dissolved in DMSO
(1.7% (v/v), nal concentration) as a solvent carrier.
Steady-state kinetic data was obtained in triplicates in 96-
well plates with readings taken every 5 s. The initial, linear
portion of the progress curve was identied by visual inspection
and tted to linear regression to give the initial rates (v) of
change in absorbance at 340 nm. These rates were converted to
molar units using the extinction coeﬃcient of NADPH (6.22
mM1 cm1)40 to give rates of reactions in micromolar
concentration of NADH formed per second.
The kinetic parameters (kcat, K0.5 and Hill coeﬃcient, h) were
obtained by plotting the rates of reaction against substrate
concentration and tting the data to the equation below using
non-linear regression as implemented in GraphPad Prism 6.0
(GraphPad Soware Inc, CA). All points were weighted equally.
v ¼ kcat[E][S]h/(K0.5h + [S]h)
where kcat is the turnover number, [E] is the enzyme concen-
tration, [S] is the concentration of substrate, K0.5 is the
concentration of substrate that produces a half-maximal
enzyme velocity (analogous to the Michaelis constant, Km, in
non-cooperative enzymes) and h is the Hill coeﬃcient.41,42Diﬀerential scanning uorimetry (DSF)
Enzyme aliquots were diluted in 50 mM HEPES, pH 7.3, to
a concentration of 5–7 mM to a nal volume of 20 ml. Sypro
Orange (10; manufacturer's concentration denition) was as
previously described.43,44 Cofactor (NADP+) and substrates were
added as appropriate. Where required, substrates were initially
dissolved in 100% DMSO and diluted in buﬀer R (50 mM
HEPES–OH, pH 7.5, 150 mM NaCl, 10% v/v glycerol) as
required. The concentration of DMSO never exceeded 1% (v/v).Fig. 1 Predicted structure of the putative vanillin dehydrogenase from
Candida dubliniensis. (a) A view of the monomer structure with an
NAD+ cofactor bound shown in stick format at the active site. (b) The
predicted tetrameric structure with each subunit in a diﬀerent colour.
(c) The predicted active site showing the bound cofactor and residue
Ile-156 (pink) which is structurally equivalent to the Met-177 in S.
cerevisiae var. boulardii Ald6p. This residue is believed to be partly
responsible for controlling access by cyclic aldehydes to the active
site.Results and discussion
Cd36_03230p is an unusual aldehyde dehydrogenase-like
protein
Structure-based multiple sequence alignment showed conserved
residues at both NAD(P)+ binding and catalytic domains.
However, the Cd36_03230p sequence has gaps and substitutions
at otherwise conserved residues when aligned to class 1, class 2
and class 3 ALDHs which suggests structural and functional
disparity (ESI Fig. S1a†). It also forms an independent cluster on
the phylogenetic tree and exhibits clear evolutionary distance
with the already known structures of class 3 benzaldehyde and
salicylaldehyde dehydrogenases with veried VDH activities,7,13
besides the class 1 and 2 ALDHs (non-VDH) (ESI Fig. S1b†).
Therefore, it is evident that Cd36_03230p sequence is not99776 | RSC Adv., 2016, 6, 99774–99780suﬃciently similar to the salicylaldehyde dehydrogenases or
benzaldehyde dehydrogenases to be classied as the member of
the class 3 vanillin dehydrogenase family.45
However, molecular modelling of Cd36_03230p predicted that
it has a similar fold to other aldehyde dehydrogenases (Fig. 1a).
The highest ranked template used in Phyre2 was PutA from G.
sulfurreducens PutA (PDB 4NMB30) with a root mean squared
deviation (rmsd) of 1.0 A˚ over 1922 equivalent atoms. The fold is
also predicted to be similar to mammalian aldehyde dehydro-
genases (for example, the rmsd when compared to sheep liver
aldehyde dehydrogenase is 0.7 A˚ over 1957 equivalent atoms).This journal is © The Royal Society of Chemistry 2016
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View Article OnlineThe predicted structure is largely a-helical with a protruding b-
sheet region at the C-terminus which is, by comparison to olig-
omeric aldehyde dehydrogenase structures, likely to be involved
in homo-oligomer assembly. Since there are both dimeric and
tetrameric aldehyde dehydrogenases known, we built both olig-
omeric versions in order to assist with the interpretation of gel
ltration experiments (see below). Comparison with the structure
of sheep liver aldehyde dehydrogenase (which was solved with
NAD+ bound) enabled the prediction of the cofactor binding site.
This lies near the surface of each subunit, adjacent to a cle
which is the likely aldehyde substrate binding site (Fig. 1b).
Previously, we have suggested that a bulky amino acid residue
(Met-177 in S. cerevisiae var. boulardii Ald6p) is partly responsible
for restricting access to bulkier, cyclic aldehydes.18 In
Cd36_03230p, the structurally equivalent residue is Ile-156.
Therefore, we hypothesized that this smaller residue may
enable Cd36_03230p to accommodate cyclic aldehydes.Expression, purication and oligomeric structure of
Cd36_03230p
Cd36_03230p could be expressed in, and puried from, E. coli
Rosetta™ (DE3) cells. Typical yields were approximately 1.5 mg
l1 of bacterial cell culture (Fig. 2a). Unlike other yeast ALDHs,18
this protein did not show multiple bands resulting fromFig. 2 Expression puriﬁcation and oligomeric state of Cd36_03230p. (a
protein. M, molecular mass markers (sizes shown to the left of the gel in
extract from bacteria after induction and immediately prior to harvesting
W1 and W2, the ﬁrst and second washes of the cobalt aﬃnity column; E
buﬀers etc., see Methods. (b) Cross-linking of Cd36_03230p (18 mM) wit
kDa); U, untreated protein; the remaining lanes had increasing concent
Cd36_03230p. On the left, the elution proﬁle of the protein. On the right
the presence of Cd36_03230p.
This journal is © The Royal Society of Chemistry 2016oligomerisation on 10% SDS-PAGE suggesting that any oligo-
meric form(s) are less resistant to heat and SDS denaturation.
The enzyme was able to form dimers and tetramers as
demonstrated by chemical crosslinking with BS3. Resolution of
the crosslinked products by 10% SDS-PAGE revealed bands cor-
responding primarily to a homotetramer (210 kDa), with some
higher order oligomers (Fig. 2b). The intensity of these bands was
greater following treatment with increasing concentrations of
BS3. Dimeric ALDHs have previously been reported in, for
example, human ALDH3 due to an extended C-terminal tail
which prevents tetramerisation.46 However, our predicted struc-
ture of Cd36_03230p suggests that there is no such tail in this
protein. Gel ltration chromatography was used to estimate the
native molecular mass in solution and, thus the subunit stoi-
chiometry. Sedimentation coeﬃcients of models of the dimeric
and tetrameric models of Cd36_03230p were computationally
estimated as 6.3 and 10.0 S respectively in order to allow for
eﬀects due to the shape of the protein. The Stoke's radius was
estimated from the gel ltration data as 5.0 nm. This yielded an
estimated subunit composition of using the dimeric model of 2.5
and 4.0 using the tetrameric model. The tetrameric model is
clearly a better t to the data, suggesting the Cd36_03230p exists
predominantly as a tetramer in solution. However, given that
higher molecular mass species were detected by crosslinking,
higher oligomeric forms may also be present.) SDS-PAGE showing the stages in expression and puriﬁcation of the
kDa); U, cell extract from bacteria prior to induction with IPTG; I, cell
by centrifugation; S, extract of soluble proteins released on sonication;
1 and E2, the ﬁrst and second elutions from the column. For details of
h BS3. M, molecular mass markers (sizes shown to the left of the gel in
rations of BS3 as indicated above the gel. (c) Analytical gel ﬁltration of
, SDS-PAGE of the fraction with the highest absorbance demonstrating
RSC Adv., 2016, 6, 99774–99780 | 99777
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View Article OnlineCd36_03230p exhibits unusual kinetic patterns with cyclic
and aromatic substrates
Cd36_03230p demonstrated activity with cyclohexane-
carboxyaldehyde (a cyclic aliphatic aldehyde), benzaldehyde
and 4-hydroxybenzaldehyde (an aromatic aldehyde), showing
highest activity towards 4-hydroxy benzaldehyde judged by its kcat
to K0.5 ratio (Table 1 and Fig. 3a). Interestingly, Cd36_03230p
kinetics also showed substantial substrate inhibition by 4-
hydroxy benzaldehyde at a substrate concentration higher than
10 mM. Despite attempts to t these data to various kinetic
models, it was not possible to obtain a good t with corre-
sponding estimates of kinetic constants for the data with this
substrate. Previously, substrate inhibition of benzaldehyde
dehydrogenases from Acinetobacter calcoaceticus by benzaldehyde
and betaine aldehyde dehydrogenase from Staphylococcus aureus
by betaine aldehyde has been reported.47,48Table 1 Steady state enzyme kinetics parameters for Cd36_03230p wit
Substrate (CAS registry number) kcat (min
1)
Cyclohexanecarboxyaldehyde (2043-61-0) 0.22  0.03
Benzaldehyde (100-52-7) 1.05  0.14
4-Hydroxybenzaldehyde (123-08-0) a
Vanillin (121-33-5) nd
a Although activity was observed with this compound, the kinetic data cou
kinetic models. b nd – no detectable turnover. Activity of Cd36_03230p wa
NADP+, varied concentrations of substrates (10–1200 mM) and 0.6 mM enzym
nal concentration of DMSO never exceeded 1% (v/v) in the assay. Values
standard errors derived from this process.
Fig. 3 Enzyme kinetics and thermal stability of Cd36_03230p. (a) The
substrates. Each point represents themean of three determinations of the
the non-linear ﬁt to the data. (b) A representative thermal denaturation e
and cyclohexane aldehyde (2 mM).
99778 | RSC Adv., 2016, 6, 99774–99780Apart from this, Cd36_03230p failed to show any activity
towards aliphatic (short-chain and long-chain) and most
aromatic aldehydes used in this study. These included acetal-
dehyde, propionaldehyde, butyraldehyde, isobutyraldehyde,
valeraldehyde, hexanaldehyde, heptanaldehyde, octanaldehyde,
nonanaldehyde, decyl aldehyde, undecyl aldehyde, dodecyl
aldehyde, tridecyl aldehyde, crotonaldehyde, DL-glyceraldehyde
and, notably, 4-hydroxy-3-methoxy benzaldehyde (vanillin).Substrates and cofactors increases thermal stability of
Cd36_03230p
Addition of NADP+ (1.5 mM) resulted in a signicant increase in
the “melting temperature”, Tm, of Cd36_03230p as estimated by
DSF (Table 2 and Fig. 3b). This suggests that this compound
binds to, and stabilizes the protein. Long-chain aliphatic and
aromatic aldehyde substrates (2 mM concentration) generallyh various substratesb
K0.5 (mM) kcat/K0.5 (mM
1 min) h
48.0  7.2 (4.6  0.2)  103 2.9  0.7
42.8  5.7 (24.5  1.5)  103 3.2  0.9
ld not be tted to Michaelis–Menten, cooperative or substrate inhibition
s assayed using 100 mM potassium phosphate buﬀer (pH 7.3), 0.5 mM
e. Aldehydes were dissolved in 1.7% (v/v) DMSO as a solvent carrier. The
reported are those returned by non-linear tting and are shown  the
protein is an active aldehyde dehydrogenase with a limited range of
rate, the error bars the standard deviations of thesemeans and the line
xperiment on Cd36_03230p (5 mM) in the presence of NADP+ (1.5 mM)
This journal is © The Royal Society of Chemistry 2016
Table 2 Thermal stability (Tm) of Cd36_03230p in the presence of
various potential substrates
Substrate or cofactor Tm (C)
Untreated 53.5  0.2
NADP+ 64.5  0.0a
Propionaldehyde 59.5  0.0a
Valeraldehyde 59.3  0.1a
Octanal 58.5  0.6a
Decanal 54.5  0.7
Tridecanaldehyde 58.0  0.3a
Crotonaldehyde 59.0  0.2a
Cyclohexanecarboxyaldehyde 57.8  0.5a
Benzaldehyde 58.0  0.4a
4-Hydroxybenzaldehyde 58.8  0.3a
Vanillin 58.0  0.3a
a Indicates a statistically signicant diﬀerence (p < 0.05). Experiments
with cofactors were compared to the appropriate untreated enzyme
and experiments with cofactor and aldehyde were compared to the
appropriate one with cofactor only. Aldehyde substrates were
measured with 2 mM aldehyde and 1.5 mM NADP+.
Communication RSC Advances
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View Article Onlinereduced the thermal stability of the enzyme–NADP+ complex by
4 C (Table 2). This may indicate a slightly lower stability of
the ternary enzyme–NADP+–aldehyde complex, perhaps result-
ing from increased overall exibility in the protein. However,
given that many of the compounds which aﬀect the thermal
stability are not substrates of the enzyme (and may, therefore,
not interact with the protein), it is also possible that they cause
a small destabilization through their general hydrophobic or
chaotropic properties rather than through interaction at
a specic site.49Conclusions
This study demonstrated that, despite being annotated as such,
this enzyme has no detectable vanillin dehydrogenase activity.
The data do show that the enzyme functions as an aldehyde
dehydrogenase, with a strong preference for some cyclic and
aromatic substrates. Our previous work suggested that a key
residue in the active site inuences the substrate specicity of
yeast aldehyde dehydrogenases. In the case of S. cerevisiae Ald4p
and Ald6p, the former has some activity to cyclic aldehyde
substrates, but the latter does not.18,50,51 Ald6p has a bulky
methionine residue (Met-177) which we hypothesized might
sterically hinder the binding of cyclic substrates. In contrast,
the structurally equivalent residue in Ald4p is Leu-196 and
alteration of Met-177 in Ald6p to valine conferred some activity
with cyclic aldehydes on this enzyme.18 In Cd36_03230p, the
structurally equivalent residue is Ile-156. This provides further
support for our hypothesis that a smaller hydrophobic residue
at this position facilitates the binding of cyclic substrates.
However, the lack of activity of Cd36_03230p with some cyclic
substrates and all aliphatic substrates tested (in contrast with S.
cerevisiae Ald4p and Ald6p which both act on aliphatic alde-
hydes) suggests that there are additional determinants of
substrate specicity in these enzymes. Further studies areThis journal is © The Royal Society of Chemistry 2016required to elucidate these. The lack of activity with vanillin
suggests that Cd36_03230p's putative annotation as a vanillin
dehydrogenase is incorrect and should be changed. We suggest
that cyclic/aromatic aldehyde dehydrogenase would be a more
appropriate annotation.Acknowledgements
This project was funded in part by the Commonwealth Schol-
arship Commission in the UK (CSC ref. no.: INCN-2014-46) as
a split-site doctoral studentship to SD. The work was also sup-
ported by Indo-UK exchange grants from University Grants
Commission, India. We thank Dr Chris CR Allen and Prof Aaron
Maule (both of School of Biological Sciences, Queen's Univer-
sity, Belfast) for access to PCR machines used for gradient PCR
and access to a qPCR machine used in the DSF assays respec-
tively. We thank Charlotte Thomas (School of Biological
Sciences, Queen's University, Belfast) for help and advice with
the computational sedimentation coeﬃcient determinations.References
1 A. A. Klyosov, Biochemistry, 1996, 35, 4457–4467.
2 A. Yoshida, A. Rzhetsky, L. C. Hsu and C. Chang, Eur. J.
Biochem., 1998, 251, 549–557.
3 A. Marchler-Bauer, M. K. Derbyshire, N. R. Gonzales, S. Lu,
F. Chitsaz, L. Y. Geer, R. C. Geer, J. He, M. Gwadz,
D. I. Hurwitz, C. J. Lanczycki, F. Lu, G. H. Marchler,
J. S. Song, N. Thanki, Z. Wang, R. A. Yamashita, D. Zhang,
C. Zheng and S. H. Bryant, Nucleic Acids Res., 2015, 43,
D222–D226.
4 H. P. Chen, M. Chow, C. C. Liu, A. Lau, J. Liu and L. D. Eltis,
Appl. Environ. Microbiol., 2012, 78, 586–588.
5 J. B. Coitinho, D. M. Costa, S. L. Guimaraes, A. M. de Goes
and R. A. Nagem, Acta Crystallogr., Sect. F: Struct. Biol. Cryst.
Commun., 2012, 68, 93–97.
6 D. Di Gioia, F. Luziatelli, A. Negroni, A. G. Ficca, F. Fava and
M. Ruzzi, J. Biotechnol., 2011, 156, 309–316.
7 W. Ding, M. Si, W. Zhang, Y. Zhang, C. Chen, L. Zhang, Z. Lu,
S. Chen and X. Shen, Sci. Rep., 2015, 5, 8044.
8 C. Fleige, G. Hansen, J. Kroll and A. Steinbuchel, Appl.
Environ. Microbiol., 2013, 79, 81–90.
9 E. Masai, Y. Yamamoto, T. Inoue, K. Takamura, H. Hara,
D. Kasai, Y. Katayama and M. Fukuda, Biosci., Biotechnol.,
Biochem., 2007, 71, 2487–2492.
10 R. Mitsui, M. Hirota, T. Tsuno and M. Tanaka, FEMS
Microbiol. Lett., 2010, 303, 41–47.
11 L. Tomas-Gallardo, H. Gomez-Alvarez, E. Santero and
B. Floriano, Microb. Biotechnol., 2014, 7, 100–113.
12 R. Singh, V. D. Trivedi and P. S. Phale, Appl. Biochem.
Biotechnol., 2014, 172, 806–819.
13 R. Plaggenborg, J. Overhage, A. Steinbuchel and H. Priefert,
Appl. Biochem. Biotechnol., 2003, 61, 528–535.
14 S. Solobodowska, J. Giebultowicz, R. Wolinowska and
P. Wroczynski, Acta Pol. Pharm., 2012, 69, 1380–1383.RSC Adv., 2016, 6, 99774–99780 | 99779
RSC Advances Communication
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
O
ct
ob
er
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
7/
03
/2
01
7 
10
:3
0:
55
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online15 R. Koncitikova, A. Vigouroux, M. Kopecna, T. Andree,
J. Bartos, M. Sebela, S. Morera and D. Kopecny, Biochem. J.,
2015, 468, 109–123.
16 T. Nakamura, H. Ichinose and H. Wariishi, Biochem. Biophys.
Res. Commun., 2010, 394, 470–475.
17 E. H. Hansen, B. L. Moller, G. R. Kock, C. M. Bunner,
C. Kristensen, O. R. Jensen, F. T. Okkels, C. E. Olsen,
M. S. Motawia and J. Hansen, Appl. Environ. Microbiol.,
2009, 75, 2765–2774.
18 S. Datta, U. S. Annapore and D. J. Timson, Appl. Biochem.
Biotechnol., 2016, under review.
19 M. M. Bradford, Anal. Biochem., 1976, 72, 248–254.
20 F. Armougom, S. Moretti, O. Poirot, S. Audic, P. Dumas,
B. Schaeli, V. Keduas and C. Notredame, Nucleic Acids Res.,
2006, 34, W604–W608.
21 P. Di Tommaso, S. Moretti, I. Xenarios, M. Orobitg,
A. Montanyola, J. M. Chang, J. F. Taly and C. Notredame,
Nucleic Acids Res., 2011, 39, W13–W17.
22 O. O'Sullivan, K. Suhre, C. Abergel, D. G. Higgins and
C. Notredame, J. Mol. Biol., 2004, 340, 385–395.
23 C. A. Morgan and T. D. Hurley, Chem.-Biol. Interact., 2015,
234, 29–37.
24 L. Ni, J. Zhou, T. D. Hurley and H. Weiner, Protein Sci., 1999,
8, 2784–2790.
25 X. Robert and P. Gouet, Nucleic Acids Res., 2014, 42, W320–
W324.
26 H. McWilliam, W. Li, M. Uludag, S. Squizzato, Y. M. Park,
N. Buso, A. P. Cowley and R. Lopez, Nucleic Acids Res.,
2013, 41, W597–W600.
27 N. Saitou and M. Nei, Mol. Biol. Evol., 1987, 4, 406–425.
28 L. A. Kelley, S. Mezulis, C. M. Yates, M. N. Wass and
M. J. E. Sternberg, Nat. Protoc., 2015, 10, 845–858.
29 E. Krieger, K. Joo, J. Lee, J. Lee, S. Raman, J. Thompson,
M. Tyka, D. Baker and K. Karplus, Proteins, 2009, 77(9),
114–122.
30 H. Singh, B. W. Arentson, D. F. Becker and J. J. Tanner, Proc.
Natl. Acad. Sci. U. S. A., 2014, 111, 3389–3394.
31 S. A. Moore, H. M. Baker, T. J. Blythe, K. E. Kitson,
T. M. Kitson and E. N. Baker, Structure, 1998, 6, 1541–1551.99780 | RSC Adv., 2016, 6, 99774–9978032 R. A. Durst and B. R. Staples, Clin. Chem., 1972, 18, 206–208.
33 T. C. Laurent and J. Killander, J. Chromatogr. A, 1964, 14,
317–330.
34 V. L. Zinsser, E. M. Hoey, A. Trudgett and D. J. Timson,
Biochimie, 2013, 95, 2182–2189.
35 A. Ortega, D. Amoros and J. Garcia de la Torre, Biophys. J.,
2011, 101, 892–898.
36 H. P. Erickson, Biol. Proced. Online, 2009, 11, 32–51.
37 G. Bare, T. Swiatkowski, A. Moukil, C. Gerday and
P. Thonart, Appl. Biochem. Biotechnol., 2002, 98–100, 415–
428.
38 X. Peng, K. Shindo, K. Kanoh, Y. Inomata, S. K. Choi and
N. Misawa, Appl. Microbiol. Biotechnol., 2005, 69, 141–150.
39 W. Yang, H. Tang, J. Ni, Q. Wu, D. Hua, F. Tao and P. Xu,
PLoS One, 2013, 8, e67339.
40 B. L. Horecker and A. Kornberg, J. Biol. Chem., 1948, 175,
385–390.
41 P. C. Engel, in LabFax Enzymology, Bio Scientic Publishers,
Oxford, UK, 1996, ch. 3.
42 D. J. Timson, Curr. Enzyme Inhib., 2015, 11, 12–31.
43 D. Devost and H. H. Zingg, J. Mol. Endocrinol., 2003, 31, 461–
471.
44 J. Tao, H. Y. Wang and C. C. Malbon, EMBO J., 2003, 22,
6419–6429.
45 V. Vasiliou, A. Bairoch, K. F. Tipton and D. W. Nebert,
Pharmacogenetics, 1999, 9, 421–434.
46 J. S. Rodriguez-Zavala and H. Weiner, Biochemistry, 2002, 41,
8229–8237.
47 R. M. Chalmers and C. A. Fewson, Biochem. J., 1989, 263,
913–919.
48 C. Chen, J. C. Joo, G. Brown, E. Stolnikova, A. S. Halavaty,
A. Savchenko, W. F. Anderson and A. F. Yakunin, Appl.
Environ. Microbiol., 2014, 80, 3992–4002.
49 J. A. Cray, J. T. Russell, D. J. Timson, R. S. Singhal and
J. E. Hallsworth, Environ. Microbiol., 2013, 15, 287–296.
50 M. F. Wang, C. L. Han and S. J. Yin, Chem.-Biol. Interact.,
2009, 178, 36–39.
51 X. Wang, C. J. Mann, Y. Bai, L. Ni and H. Weiner, J. Bacteriol.,
1998, 180, 822–830.This journal is © The Royal Society of Chemistry 2016
